Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

6.63

-0.22 (-3.21%)

At close: Mar 12, 2026, 4:00 PM EDT

6.58

-0.05 (-0.75%)

After-hours: Mar 12, 2026, 6:39 PM EDT

Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	41	35.01	121.47	77.34	135.86	29.37
Short-Term Investments	81.77	86.5	-	-	-	-
Cash & Short-Term Investments	122.76	121.52	121.47	77.34	135.86	29.37
Cash Growth	-21.82%	0.04%	57.06%	-43.08%	362.53%	-
Other Current Assets	5.03	4.6	2.83	2.71	0.82	0.03
Total Current Assets	127.79	126.12	124.29	80.05	136.68	29.41
Net Property, Plant & Equipment	9.41	10.56	12.26	13.78	0.17	-
Long-Term Investments	3.39	7.01	-	-	-	-
Other Long-Term Assets	3.25	3.25	3.25	3.25	0	0
Total Assets	143.84	146.94	139.81	97.08	136.86	29.41
Accounts Payable	4.66	6.42	3.79	2.68	3.06	0.04
Accrued Expenses	9.9	13.76	10.84	8.33	3.81	0.25
Current Portion of Leases	2.72	2.67	2.61	2.83	-	-
Unearned Revenue	-	-	-	-	0.05	0.14
Other Current Liabilities	-	-	-	0.51	0.53	0.26
Total Current Liabilities	17.27	22.85	17.24	14.35	7.45	0.7
Long-Term Leases	5.74	7.25	9.03	10.65	-	-
Other Long-Term Liabilities	-	-	-	-	-	3.01
Total Long-Term Liabilities	5.74	7.25	9.03	10.65	-	3.01
Total Liabilities	23.01	30.1	26.27	25	7.45	3.71
Common Stock	0.01	0	0	-	-	0
Treasury Stock	-0.02	-0.02	-	-	-	-
Additional Paid-in Capital	479.97	397.13	295.37	2.49	0.57	0.01
Accumulated Other Comprehensive Income	0.09	-0.1	-	-	-	-
Retained Earnings	-359.22	-280.17	-181.84	-115.45	-56.17	-5.55
Total Common Shareholders' Equity	120.83	116.84	113.54	-112.95	-55.6	-5.54
Minority Interest	-	-	-	185.03	185.01	31.24
Shareholders' Equity	120.83	116.84	113.54	72.08	129.41	25.7
Total Liabilities & Equity	143.84	146.94	139.81	97.08	136.86	29.41
Total Debt	8.46	9.92	11.64	13.48	0	0
Net Cash (Debt)	114.31	111.59	109.83	63.85	135.86	29.37
Net Cash Growth	2.43%	1.61%	72.00%	-53.00%	362.53%	-
Net Cash Per Share	2.68	3.51	20.51	39.16	87.50	20.38
Book Value	120.83	116.84	113.54	-112.95	-55.6	-5.54
Book Value Per Share	2.83	3.68	21.20	-69.28	-35.81	-3.84
Tangible Book Value	120.83	116.84	113.54	-112.95	-55.6	-5.54
Tangible Book Value Per Share	2.83	3.68	21.20	-69.28	-35.81	-3.84

Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q